STAA Q2 2022 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$81M+30.0% YoY

Gross Profit

$64M78.8% margin

Operating Income

$17M21.0% margin

Net Income

$13M16.1% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+28.3%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$8M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$376M

Total Liabilities

$77M

Stockholders' Equity

$299M

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$62M	+30.0%
Gross Profit	$64M	$49M	+29.8%
Operating Income	$17M	$11M	+59.8%
Net Income	$13M	$9M	+52.2%

Revenue Segments

Implantable Collamer Lenses

$78M96%

Cataract Intraocular Lenses

$3M3%

Other Surgical Products

$632,0001%